Author:
Pérez Carlos A.,Zhang Guo-Qiang,Li Xiaojin,Huang Yan,Lincoln John A.,Samudralwar Rohini D.,Gupta Rajesh K.,Lindsey John W.
Subject
Neurology (clinical),Neurology,General Medicine
Reference31 articles.
1. SARS-CoV-2 and multiple sclerosis: Not all immune depleting DMTs are equal or bad;Amor;Ann. Neurol.,2020
2. COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual?;Brownlee;Mult. Scler. J.,2020
3. Multiple sclerosis and COVID-19: how many are at risk?;Bsteh;Eur. J. Neurol.,2020
4. COVID-19 pandemic: The experience of a multiple sclerosis centre in Chile;Ciampi;Mult. Scler. Relat. Disord.,2020
5. Multiple sclerosis disease-modifying therapies in the COVID-19 era;Ciotti;Ann. Neurol.,2020
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献